Skip to content
Sharism- Lifestyle
Author:
4D Molecular Therapeutics, Inc.
4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD
June 29, 2026
4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital
June 29, 2026
4DMT Announces New Employment Inducement Grants
June 12, 2026
4DMT to Participate in Upcoming Investor Conferences
May 27, 2026
4DMT Announces New Employment Inducement Grants
May 15, 2026
4DMT Reports First Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones
May 7, 2026
4DMT to Participate in Upcoming Investor Conferences
May 4, 2026
4DMT Announces New Employment Inducement Grants
April 17, 2026
4DMT Reports Full Year 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
March 18, 2026
4DMT to Participate in Upcoming Investor Meetings
March 16, 2026